Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Domiciliary oxygen for chronic obstructive pulmonary disease.

A J Crockett1, J M Cranston, J R Moss

  • 1Respiratory Unit, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, AUSTRALIA, 5042. alan.crockett@flinders.edu.au

The Cochrane Database of Systematic Reviews
|October 18, 2000
PubMed
Summary

Long term oxygen therapy improves survival for severe hypoxemic COPD patients. It does not significantly benefit those with moderate hypoxemia or nocturnal desaturation alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme.

Expert review of pharmacoeconomics & outcomes research·2015
Same author

Exploring policy makers' perspectives on a clinical controversy: airway surgery for adult obstructive sleep apnoea.

Quality & safety in health care·2009
Same author

Efficiency measurement for hospitals owned by the Iranian social security organisation.

Journal of medical systems·2007
Same author

Domiciliary oxygen for chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews·2005
Same author

[Self assessment quality of life and lung diseases (SAQOL in patients with pulmonary carcinoma: influence to survival and impact of chronic obstructive pulmonary disease].

Pneumologie (Stuttgart, Germany)·2005
Same author

Implementation of a split-night protocol to improve efficiency in assessment and treatment of obstructive sleep apnoea.

Internal medicine journal·2005

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine

Background:

  • Domiciliary oxygen therapy is a primary treatment for hypoxemic chronic obstructive pulmonary disease (COPD).
  • Evidence regarding its impact on long-term outcomes is crucial for clinical practice.

Purpose of the Study:

  • To evaluate the effect of domiciliary oxygen therapy on survival and quality of life in COPD patients.
  • To synthesize findings from randomized controlled trials (RCTs) on long-term oxygen use.

Main Methods:

  • Systematic review of RCTs identified through the Cochrane Airways Group COPD register.
  • Inclusion criteria: RCTs in hypoxemic COPD patients comparing long-term domiciliary oxygen with control.
  • Data extraction performed independently by two reviewers.

Related Experiment Videos

Main Results:

  • Five RCTs were identified; data aggregation was possible for only two trials.
  • Continuous oxygen therapy showed improved mortality in one trial (24 months).
  • Domiciliary oxygen therapy demonstrated improved mortality in another trial (5 years).
  • No significant mortality benefit was observed for nocturnal oxygen therapy or in moderate hypoxemia.

Conclusions:

  • Long-term oxygen therapy enhances survival in selected COPD patients with severe hypoxemia (PaO2 < 8.0 kPa).
  • Oxygen therapy did not improve survival in patients with moderate hypoxemia or isolated nocturnal desaturation.